Russia mandates domestic clinical trials for new imported veterinary drugs

The State Duma passed the first reading of a bill requiring clinical trials of unregistered imported veterinary drugs to be conducted only in Russia. This is a protectionist measure aimed at reducing foreign dependence in the veterinary pharmaceutical sector, potentially complicating market access for foreign manufacturers. The bill's passage through subsequent readings remains uncertain, but it signals a continued trend of import substitution in Russian regulatory policy.